Luteinising hormone releasing hormone agonist in women with endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (4)

• Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data via openalex
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis via openalex
• W1999683827 via openalex
• W2395322658 via openalex

Cited by (6)

• Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group 1990
• Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
• Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile 1990
• GnRH analogues in the treatment of endometriosis 1989
• Treatment of Endometriosis by Nasal Administration of Nafarelin 1987

Source provenance

europepmc

last seen: 2026-10-15T06:08:49.021275+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-10-08T21:58:08.863946+00:00

unpaywall

last seen: 2026-10-15T06:24:24.424788+00:00